The resurgence of covalent drugs - PubMed (original) (raw)
Review
doi: 10.1038/nrd3410.
Affiliations
- PMID: 21455239
- DOI: 10.1038/nrd3410
Review
The resurgence of covalent drugs
Juswinder Singh et al. Nat Rev Drug Discov. 2011 Apr.
Abstract
Covalent drugs have proved to be successful therapies for various indications, but largely owing to safety concerns, they are rarely considered when initiating a target-directed drug discovery project. There is a need to reassess this important class of drugs, and to reconcile the discordance between the historic success of covalent drugs and the reluctance of most drug discovery teams to include them in their armamentarium. This review surveys the prevalence and pharmacological advantages of covalent drugs, discusses how potential risks and challenges may be addressed through innovative design, and presents the broad opportunities provided by targeted covalent inhibitors.
Similar articles
- Follow-on drugs: how far should chemists look?
Giordanetto F, Boström J, Tyrchan C. Giordanetto F, et al. Drug Discov Today. 2011 Aug;16(15-16):722-32. doi: 10.1016/j.drudis.2011.05.011. Epub 2011 May 27. Drug Discov Today. 2011. PMID: 21658467 - Approaches to mitigate the risk of serious adverse reactions in covalent drug design.
Baillie TA. Baillie TA. Expert Opin Drug Discov. 2021 Mar;16(3):275-287. doi: 10.1080/17460441.2021.1832079. Epub 2020 Oct 19. Expert Opin Drug Discov. 2021. PMID: 33006907 Review. - Predicting toxicities of reactive metabolite-positive drug candidates.
Kalgutkar AS, Dalvie D. Kalgutkar AS, et al. Annu Rev Pharmacol Toxicol. 2015;55:35-54. doi: 10.1146/annurev-pharmtox-010814-124720. Epub 2014 Oct 6. Annu Rev Pharmacol Toxicol. 2015. PMID: 25292426 Review. - The importance of drug-target residence time.
Zhang R, Monsma F. Zhang R, et al. Curr Opin Drug Discov Devel. 2009 Jul;12(4):488-96. Curr Opin Drug Discov Devel. 2009. PMID: 19562645 Review. - Drug discovery beyond the rule of 5 - Opportunities and challenges.
Doak BC, Kihlberg J. Doak BC, et al. Expert Opin Drug Discov. 2017 Feb;12(2):115-119. doi: 10.1080/17460441.2017.1264385. Epub 2016 Dec 8. Expert Opin Drug Discov. 2017. PMID: 27883294 No abstract available.
Cited by
- A targeted covalent small molecule inhibitor of HIV-1 fusion.
Zhou G, He L, Li KH, Pedroso CCS, Gochin M. Zhou G, et al. Chem Commun (Camb). 2021 May 6;57(37):4528-4531. doi: 10.1039/d1cc01013a. Chem Commun (Camb). 2021. PMID: 33956029 Free PMC article. - Racemases and epimerases operating through a 1,1-proton transfer mechanism: reactivity, mechanism and inhibition.
Lloyd MD, Yevglevskis M, Nathubhai A, James TD, Threadgill MD, Woodman TJ. Lloyd MD, et al. Chem Soc Rev. 2021 May 24;50(10):5952-5984. doi: 10.1039/d0cs00540a. Chem Soc Rev. 2021. PMID: 34027955 Free PMC article. Review. - An androgen receptor N-terminal domain antagonist for treating prostate cancer.
Myung JK, Banuelos CA, Fernandez JG, Mawji NR, Wang J, Tien AH, Yang YC, Tavakoli I, Haile S, Watt K, McEwan IJ, Plymate S, Andersen RJ, Sadar MD. Myung JK, et al. J Clin Invest. 2013 Jul;123(7):2948-60. doi: 10.1172/JCI66398. Epub 2013 Jun 3. J Clin Invest. 2013. PMID: 23722902 Free PMC article. - Computational Approaches for the Discovery of Human Proteasome Inhibitors: An Overview.
Guedes RA, Serra P, Salvador JA, Guedes RC. Guedes RA, et al. Molecules. 2016 Jul 16;21(7):927. doi: 10.3390/molecules21070927. Molecules. 2016. PMID: 27438821 Free PMC article. Review. - Concise Total Syntheses of (-)-Crinipellins A and B Enabled by a Controlled Cargill Rearrangement.
Xu B, Zhang Z, Tantillo DJ, Dai M. Xu B, et al. J Am Chem Soc. 2024 Aug 7;146(31):21250-21256. doi: 10.1021/jacs.4c07900. Epub 2024 Jul 25. J Am Chem Soc. 2024. PMID: 39052841 Free PMC article.
References
- Chem Res Toxicol. 2006 Jul;19(7):889-93 - PubMed
- Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):12022-7 - PubMed
- Pharmacol Ther. 1999 May-Jun;82(2-3):207-18 - PubMed
- Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):923-46 - PubMed
- Nat Chem Biol. 2011 Jan;7(1):22-4 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical